Rising incidence of neurological disorders worldwide is redefining the landscape of neurology care and driving record growth in the global neurology market. the neurology market is projected to reach approximately USD 3.72 billion, with expectations to grow at a compound annual growth rate (CAGR) of 7.55%, potentially reaching USD 6.66 billion by 2032. Conditions such as Alzheimer’s disease, Parkinson’s disease, epilepsy, multiple sclerosis, and stroke are creating strong demand for innovative therapeutics, advanced diagnostic solutions, and patient-centered care models. Major neurology industry leaders, including F. Hoffmann-La Roche, Novartis, UCB, and Otsuka, are spearheading investments in AI-assisted diagnostics, neurostimulation devices, gene therapies, wearable neurology technology, and precision medicine, aiming to improve treatment efficacy and clinical outcomes. The integration of telehealth services, digital therapeutics, and minimally invasive procedures is further transforming how neurological care is delivered, emphasizing accessibility, affordability, and convenience for patients.
Neurology overview
Published by MMR Statistics Research Team, Updated